RT Journal Article
SR Electronic
T1 Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – An open labelled, Parallel Group, Randomized controlled clinical trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.10.21261836
DO 10.1101/2021.08.10.21261836
A1 bhardwaj, Pankaj
A1 Godatwar, Pawan Kumar
A1 Charan, Jaykaran
A1 Sharma, Sanjeev
A1 Shafi, Shazia
A1 Chauhan, Nishant
A1 Vyas, Pratibha
A1 Dutt, Naveen
A1 Midha, Naresh
A1 Jalandra, Ramniwas
A1 Sharma, Meenakshi
A1 Nag, Vijaya Lakshmi
A1 Sharma, Suman
A1 Singh, Sarvesh Kumar
A1 Sharma, Praveen
A1 Misra, Sanjeev
YR 2021
UL http://medrxiv.org/content/early/2021/09/27/2021.08.10.21261836.abstract
AB The authors have withdrawn this manuscript because they found a serious issue in data-analysis which leads to wrong interpretation of the results. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCTRI/2020/06/026002Funding StatementThis study was funded by National Institute of Ayurveda. (An autonomous body under the ministry of AYUSH), Madhav Vilas Palace, Jorawar Singh Gate, Amer Road, Jaipur-302002 (Rajasthan), India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human Ethics Committee of All India Institute of Medical Sciences, JodhpurAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available with Principal Investigator - Dr. Pankaj Bhardwaj